Vasiliadis Helen-Maria, Roberge Pasquale, Shen-Tu Grace, Vena Jennifer
Faculty of Medicine and Health Sciences, Université de Sherbrooke, 2500, boul. de l'Université, Sherbrooke, Québec, J1K 2R, Canada.
Centre de Recherche Charles-Le Moyne, 150, place Charles‑Le Moyne, C. P. 200, Longueuil, Québec, J4K 0A8, Canada.
Int J Ment Health Syst. 2024 Dec 23;18(1):36. doi: 10.1186/s13033-024-00653-7.
Effective mental healthcare coverage (EMHC) is an important health system performance indicator of a population's mental healthcare needs. This study aims to assess the factors and healthcare costs associated with the receipt of EMHC for anxiety and depression.
This study draws on data from participants from Alberta's Tomorrow Project with moderate or severe symptoms of anxiety and depression during the first wave of the COVID-19 pandemic (2020) with available medico-administrative and complete data [n = 720]. EMHC was assessed during the eighteen months as of March 1, 2020, and defined as adequate pharmacotherapy (i.e., antidepressant dispensed, with ≥ 80% proportion of days covered and 4 follow-up medical visits) and/or adequate psychotherapy (≥ 8 physician consultations for psychotherapy) depending on the severity of symptoms. Logistic regression analysis was used to study EMHC as a function of study variables. Regressions with augmented inverse probability weighting were used to estimate the total healthcare costs attributable to receipt of EMHC during the first 18-month period of the pandemic, controlling for confounders. Mean adjusted differences with 95% bias-corrected bootstrap confidence intervals (CIs) are presented.
The proportion receiving EMHC was 26.7%. Individuals with worse self-rated mental health after the pandemic than before were less likely to receive EMHC. Those with a lifetime diagnosis of depression and anxiety were more likely to receive EMHC. The overall mean adjusted total healthcare costs attributable to receipt of EMHC during the pandemic was $2601 [ - $247, $5694]. The mean adjusted outpatient costs attributable to EMHC was significantly higher and reached $1613 [$873, $2577].
The study's findings highlight the existence of health inequalities and potential unmet mental health needs in individuals with worsening mental health during the pandemic. The receipt of EMHC during the pandemic was not significantly associated with increased total healthcare costs. These findings underscore the need for mental health policies that are aimed at improving timely access to EMHC to address population unmet mental health service needs.
有效的精神卫生保健覆盖(EMHC)是衡量人群精神卫生保健需求的一项重要卫生系统绩效指标。本研究旨在评估与接受焦虑和抑郁的EMHC相关的因素及医疗费用。
本研究利用了来自艾伯塔省明日项目参与者的数据,这些参与者在2019年冠状病毒病大流行第一波(2020年)期间有中度或重度焦虑和抑郁症状,且有可用的医疗管理数据且数据完整[n = 720]。截至2020年3月1日的18个月内对EMHC进行评估,根据症状严重程度将其定义为充分的药物治疗(即配用抗抑郁药,覆盖天数比例≥80%且有4次随访医疗就诊)和/或充分的心理治疗(≥8次心理治疗医生会诊)。采用逻辑回归分析研究EMHC作为研究变量的函数。使用增强逆概率加权回归来估计大流行前18个月期间接受EMHC所导致的总医疗费用,并控制混杂因素。给出了具有95%偏差校正自助置信区间(CI)的平均调整差异。
接受EMHC的比例为26.7%。大流行后自我评定心理健康状况比之前更差的个体接受EMHC的可能性较小。有终生抑郁和焦虑诊断的个体更有可能接受EMHC。大流行期间接受EMHC所导致的总体平均调整后总医疗费用为2601美元[-247美元,5694美元]。归因于EMHC的平均调整后门诊费用显著更高,达到1613美元[873美元,2577美元]。
该研究结果凸显了大流行期间心理健康状况恶化的个体中存在健康不平等以及潜在未满足的心理健康需求。大流行期间接受EMHC与总医疗费用增加无显著关联。这些发现强调了需要制定旨在改善及时获得EMHC的心理健康政策,以满足人群未满足的心理健康服务需求。